Cardiovascular Risk Stratification of Ambulatory Patients in Primary Prevention. RISK Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 516
- 试验地点
- 1
- 主要终点
- Desciption of the assessment methods used to define the cardiovascular risk profile of patients attending outpatient medical consultation.
研究概览
简要总结
This is an observational, cross-sectional, national multicenter study, trying to obtain local data about the global cardiovascular risk profile of patients attending ambulatory offices of general practitioners and cardiologists.
The aim of the study is to describe how physicians diagnose and stratify their patients in cardiovascular primary prevention setting and to highlight if patients are stratify through objective tools (risk scores and in this case, wich of them are used) or in subjective ways (clinical evaluation).
详细描述
This is an observational, cross-sectional, national multicenter study, trying to obtain local data about the global cardiovascular risk profile of patients attending ambulatory offices of general practitioners and cardiologists.
The aim of the study is to describe how physicians diagnose and stratify their patients in cardiovascular primary prevention setting and to highlight if patients are stratify through objective tools (risk scores and in this case, wich of them are used) or in subjective ways (clinical evaluation).
研究设计
- 研究类型
- Observational
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients older than 18 years of age, who give their written consent to take part.
- •Patients without known vascular disease (primary prevention) under follow-up by the investigator, whose medical records have been initiated during the last 3 years.
- •Patients who have completed their baseline CV risk assessment Lipid lowering treatment naive patients at the time of the stratification.
排除标准
- •Incomplete or missing medical record data.
- •Subjects with prior cardiovascular disease (peripheral vascular disease, coronary or cerebrovascular disease) symptomatic or asymptomatic.
- •Subjects with terminal status disease or short life expectancy.
- •Hypothyroidism without proper control.
- •Pregnancy.
- •Medical records compiled within a period longer than 3 years to the date of inclusion.
结局指标
主要结局
Desciption of the assessment methods used to define the cardiovascular risk profile of patients attending outpatient medical consultation.
时间窗: Day 1
It will be evaluated the cardiovascular risk score for each patient. The proportion of use of each of the validated risk scores, as a tool of individual cardiovascular risk stratification and the proportion of use of a subjective assessment as tools of individual cardiovascular risk stratification used by general practitioners and cardiologists will be described.
次要结局
- Comparison of the subjective individual risk assessment vs. the objective assessment obtained by the WHO risk score.(Day 1)
- Description of the extent of use of other diagnostic methods to define the individual cardiovascular risk (imaging scans, biomarkers).(Day 1)
- Comparison of the objective individual risk assessment achieved by the use of any risk score chosen by the treating physician in his / her usual practice vs. the objective assessment obtained by WHO risk score.(Day 1)
- Description of the treatment used, according to risk group and by the specialty of the treating physician.(Day 1)